IRWD

Ironwood Pharmaceuticals Inc.

Price

$4.36

return (12m)

307.48%

p/e

5.29

p/bv

-4.24

DIVIDEND YIELD

0.00%

IRWD price

Ironwood Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IRWD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

13.39%

3 months

13.25%

1 year

307.48%

2 years

-8.40%

5 years

-66.72%

10 years

-68.39%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals IRWD

Valuation

P/E

5.29

Sector -4.38

Industry -4.38

P/BV

-4.24

Sector 2.02

Industry 2.02

P/Revenue (PSR)

1.76

Sector -4.40

Industry -4.40

EV/EBITDA

12.19

Sector -263.09

Industry -263.09

EV/EBIT

12.26

Sector -702.90

Industry -702.90

P/EBITDA

2.84

Sector -4.39

Industry -4.39

P/EBIT

2.86

Sector -4.73

Industry -4.73

P/Total Assets

2.41

Sector 1.49

Industry 1.49

P/Net Current Assets

-2.77

Sector -11.70

Industry -11.70

P/Working Capital

4.13

Sector -3.19

Industry -3.19

EPS

0.79

Sector -2.14

Industry -2.14

BVPS

-0.99

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

72.00%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

71.59%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

60.64%

Sector -38.22%

Industry -38.22%

Net Profit Margins

33.36%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.40

Sector 0.03

Industry 0.03

Profitability

ROE

-80.24%

Sector -65.14%

Industry -65.14%

ROA

45.54%

Sector -65.53%

Industry -65.53%

ROIC

86.88%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

6.06

Sector 2.90

Industry 2.90

Net Debt / EBITDA

3.76

Sector -6.07

Industry -6.07

Net Debt / EBIT

3.78

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.89

Sector -1.07

Industry -1.07

Gross Debt / Equity

-2.38

Sector -0.05

Industry -0.05

Equity/Assets

-0.57

Sector 0.41

Industry 0.41

Liabilities/Assets

1.57

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-1.21%

Sector -

Industry -

5Y Earnings CAGR

-24.47%

Sector -

Industry -

Fundamentals IRWD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IRWD Ironwood Pharmaceuticals Inc.	$4.36	285.84%	0.00%	5.29	-4.24	-80.24%	33.36%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IRWD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Ironwood Pharmaceuticals

Ironwood Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

28 years

Founded: 1998

2010

Time since IPO - 16 years

674

Employees

Ironwood Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $686.34 million, with shareholders equity totaling $-161.84 million.

The company employs approximately 674 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Ironwood Pharmaceuticals Inc. reported $389.32 million in revenue, generating net income of $129.86 million.

Key financial metrics include a P/E ratio of 5.29, a price-to-book (P/B) ratio of -4.24, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IRWD.

Market cap

$686.34 million

Net worth

$-161.84 million

$-161,840,000.00

Assets

$285.13 million

$285,130,000.00

Total Shares Outstanding

164.00 million

164,000,000

Average Daily Trading Volume

$2.40 million

$2,397,312.74

Sector

Health Care

Industry

Biotechnology

IRWD

IRWD revenue and profits

Financial Results IRWD

DRAG THE FRAME TO SEE MORE DATA

IRWD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Ironwood Pharmaceuticals (IRWD) today?

A cotação de Ironwood Pharmaceuticals (IRWD) hoje está em US$ 4.36, com uma variação de 307.48% em relação ao último ano. A cotação de Ironwood Pharmaceuticals (IRWD) iniciou o ano negociando na casa dos US$ 3.37 e hoje está em US$ 4.36. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Ironwood Pharmaceuticals (IRWD) e dados de ações do Ibovespa e mercados internacionais.

Quando Ironwood Pharmaceuticals (IRWD) paga dividendos?

Ironwood Pharmaceuticals (IRWD) não distribuiu dividendos no último ano.

Is Ironwood Pharmaceuticals (IRWD) a good investment?

Atualmente, Ironwood Pharmaceuticals (IRWD) está cotada a US$ 4.36, com um P/L de 5.29, representando um desvio de 16,485% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 307.48 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 307.48%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Ironwood Pharmaceuticals (IRWD) stock?

Investir em ações de Ironwood Pharmaceuticals (IRWD) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Ironwood Pharmaceuticals (IRWD) yield today?

A rentabilidade de Ironwood Pharmaceuticals (IRWD) foi de 13.39% no último mês, 307.48% no último ano e -66.72% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Ironwood Pharmaceuticals (IRWD) hoje, o investimento total seria de US$ 436.00, com base na cotação atual de US$ 4.36.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,776.61
Em 5 anos: US$ 145.10
Em 10 anos: US$ 137.82

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

IRWD

Ironwood Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment IRWD

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING IRWD WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Ironwood Pharmaceuticals

Ironwood Pharmaceuticals Inc.

United States

28 years

2010

674

PROFIT X PRICE IRWD

Financial Results IRWD

IRWD cash flow

Asset, Revenue and Profit Growth - IRWD

IRWD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions